Partner Content Partner Content Prescient Intelligence & Insight Announces Recent Appointmen... Prescient Intelligence & Insight hires 3 senior leads
News GSK must continue to improve R&D, says CEO Walmsley It’s been two and a half years since Emma Walmsley took over as CEO of GlaxoSmithKline, and at the time was seen as the protégé of her predecessor Sir Andrew Witty.
Partner Content Partner Content Kristin Milburn joins Healthware Group as Global Head of Dig... We are pleased to announce Kristin Milburn has joined
Partner Content Partner Content Three strategies for managing loss of exclusivity successful... Effectively planning your LOE strategy
Events Partner Content 8th Annual Pharma CI Europe Conference & Exhibition The Best Assembly of Competitive Intelligence Experts
News Gilead's twice-yearly PrEP drug is cleared by FDA Gilead has FDA approval for a twice-yearly PrEP drug, but could proposed cuts to US funding for HIV prevention programmes hinder its take-up?
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face
